Avalo TherapeuticsAVTX
13F holders, Q1 2025 (March 31)34holders +1
5new positions
4sold out
$8.01avg. 13F price*
At the end of Q1 2025, 34 institutions reported holding Avalo Therapeutics Inc. (AVTX) in their 13F filings, up 1 from Q4 2024. 5 opened new positions and 4 sold out. The largest holders were BVF Inc. ($8.3M), Orbimed Advisors LLC ($7.7M) and Ra Capital Management, L.P. ($7.7M).
- Company
- Avalo Therapeutics Inc.
- CUSIP
- 05338F306
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $14.0M |
| Exits | 4 | $1.8M |
All 13F filers, Q4 2024 → Q1 2025: 1,892,224 shares bought and 1,167,683 shares sold, net +724,541 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 34 holders
| BVF Inc. | 0.34% | No change | 1,036,679 | $8.3M |
| Orbimed Advisors LLC | 0.19% | No change | 967,000 | $7.7M |
| Ra Capital Management, L.P. | 0.13% | No change | 967,000 | $7.7M |
| Nantahala Capital Management, LLC | 0.60% | New | 900,000 | $7.2M |
| Deep Track Capital, LP | 0.22% | Reduce -0.8% | 859,876 | $6.9M |
| Affinity Asset Advisors, LLC | 0.87% | Add +19.3% | 657,154 | $5.3M |
| Perceptive Advisors LLC | 0.15% | New | 520,000 | $4.2M |
| TCG Crossover Management, LLC | 0.53% | No change | 483,000 | $3.9M |
| Commodore Capital LP | 0.29% | No change | 483,000 | $3.9M |
| Rwa Wealth Partners, LLC | 0.03% | New | 312,779 | $2.5M |
| Ikarian Capital, LLC | 0.52% | Reduce -79.4% | 200,000 | $1.6M |
| Vanguard Group Inc. | 0.00% | Add +0.7% | 166,941 | $1.3M |
| BlackRock, Inc. | 0.00% | Add +0.4% | 133,726 | $1.1M |
| Velan Capital Investment Management LP | 0.92% | Add +1.8% | 111,972 | $897K |
| Geode Capital Management, LLC | 0.00% | Add +2.8% | 107,812 | $864K |
| Allostery Investments LP | 1.24% | Add +46.1% | 107,141 | $858K |
| UBS Group AG | 0.00% | Add +0.4% | 98,951 | $793K |
| Sio Capital Management, LLC | 0.17% | No change | 71,458 | $572K |
| Northern Trust Corp. | 0.00% | No change | 22,673 | $182K |
| Walleye Capital LLC | 0.00% | Add +3.8% | 20,223 | $162K |
| HRT Financial LP | 0.00% | Reduce -74.3% | 10,289 | $82K |
| ADAR1 Capital Management, LLC | 0.02% | New | 10,000 | $80K |
| Bank of America Corp. | 0.00% | Add +0.1% | 5,673 | $45K |
| JPMorgan Chase & Co. | 0.00% | Add +55150.0% | 1,105 | $9K |
| Morgan Stanley | 0.00% | Add +3500.0% | 360 | $3K |
| Royal Bank of Canada | 0.00% | Reduce -99.8% | 212 | $2K |
| SBI Securities Co., Ltd. | 0.00% | No change | 22 | $176 |
| BNP Paribas Financial Markets | 0.00% | No change | 4 | $32 |
| Group One Trading LLC | 0.00% | No change | 2 | $16 |
| Osaic Holdings, Inc. | 0.00% | No change | 2 | $16 |
| Parallel Advisors, LLC | 0.00% | No change | 1 | $8 |
| Key Financial Inc | 0.00% | No change | 1 | $8 |
| Activest Wealth Management | 0.00% | No change | 1 | $8 |
| Avion Wealth | 0.00% | New | 5 | $0 |
"% of holder's portfolio" is AVTX's weight in each manager's 13F, not the share of Avalo Therapeutics Inc. the manager owns.